Tactile Systems Technology Inc (NASDAQ:TCMD) COO Robert J. Folkes sold 1,500 shares of the company’s stock in a transaction dated Wednesday, January 10th. The stock was sold at an average price of $28.32, for a total value of $42,480.00. Following the transaction, the chief operating officer now directly owns 119,777 shares of the company’s stock, valued at $3,392,084.64. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Shares of Tactile Systems Technology Inc (NASDAQ TCMD) opened at $29.41 on Monday. The stock has a market capitalization of $520.61, a PE ratio of 94.87, a P/E/G ratio of 6.58 and a beta of -0.60. Tactile Systems Technology Inc has a 1 year low of $14.37 and a 1 year high of $37.88.
Tactile Systems Technology (NASDAQ:TCMD) last announced its earnings results on Tuesday, November 7th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.02. The firm had revenue of $28.28 million during the quarter, compared to analysts’ expectations of $27.66 million. Tactile Systems Technology had a return on equity of 4.75% and a net margin of 5.84%. The business’s revenue was up 25.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.01 EPS. research analysts anticipate that Tactile Systems Technology Inc will post 0.34 EPS for the current year.
Several research firms have recently issued reports on TCMD. BidaskClub cut Tactile Systems Technology from a “hold” rating to a “sell” rating in a research report on Saturday, January 6th. Canaccord Genuity reaffirmed a “buy” rating and set a $37.00 price objective on shares of Tactile Systems Technology in a research report on Wednesday, January 3rd. Sidoti began coverage on Tactile Systems Technology in a research report on Friday, December 8th. They set a “neutral” rating for the company. Zacks Investment Research raised Tactile Systems Technology from a “hold” rating to a “strong-buy” rating and set a $28.00 price objective for the company in a research report on Friday, November 10th. Finally, BTIG Research raised Tactile Systems Technology from a “neutral” rating to a “buy” rating in a research report on Thursday, November 9th. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, three have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $34.25.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency.
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.